During phase two, GSK will collaborate with interested companies to better understand their specific plans for the future and to conduct a more thorough analysis through factory visits included. “This will help us select the best offers with which to move forward in the selling process. We believe this phase will be completed by the end of the first quarter of 2014,” according to the same cited source.

GSK representatives have stated that if no satisfactory buyers are identified during this second project phase, the factory will close. “Since the initial announcement was made, GSK has been seeking opportunities to sell the site in Brasov to a third party through a transient production agreement, which would ensure the continuance of Brasov factory products supply until the production is transferred to other GSK sites or external producers. (Source: nineoclock.ro)